Our Pipeline
The projects of our four platforms are steadily advancing. The two projects with the fastest progress are ET-01 for severe β-thalassemia and U CAR-T ET-02 for cancer.
The projects of our four platforms are steadily advancing. The two projects with the fastest progress are ET-01 for severe β-thalassemia and U CAR-T ET-02 for cancer.
Follow us on WeChat
Careers : hr@EdiGene.com
Partnership : bd@EdiGene.com
Media Inquiries : media@EdiGene.com